Fig. 2From: Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case reportClinical course. After initiating prednisolone therapy, this patient underwent four cycles of BD therapy (bortezomib at 1.3 mg/m2/week, and dexamethasone at 20 mg/week), followed by bortezomib maintenance therapy (1.3 mg/m2, biweekly). The κ/λ ratio, urinary protein (UP), and eGFR (calculated using equations for Japanese [26]) results are shown over the course of treatmentBack to article page